Biote CORP Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
NASDAQ
BTMD
Biote CORPForm 4: biote Executive Buys Shares
Marc D Beer, Executive Chairman and a Director of biote Corp., purchased 131,950 shares of common stock on August 10, 2026.
NASDAQ
BTMD
Biote CORPBiote Corp. Interim CEO Robert Peterson was granted 206,746 stock options as part of his compensation package.
NASDAQ
BTMD
Biote CORPDirector Bret Christensen was granted 130,000 stock options in Biote Corp. with an exercise price of $2.34.
NASDAQ
BTMD
Biote CORPExecutive Chairman Marc D. Beer was granted 114,157 employee stock options in Biote Corp. with an exercise price of $2.34.
NASDAQ
BTMD
Biote CORPDirector Debra L. Morris reported the acquisition of Class A Common Stock and new equity awards in Biote Corp.
NASDAQ
BTMD
Biote CORPDirector Stephen Mark Cone was granted 31,481 deferred settlement RSUs and 130,000 stock options by Biote Corp.
NASDAQ
BTMD
Biote CORPDirector Dana Lynn Jacoby was granted 37,777 deferred settlement RSUs and 130,000 stock options by Biote Corp.
NASDAQ
BTMD
Biote CORPDirector Marc D. Beer was granted 195,000 stock options in Biote Corp. with an exercise price of $2.20.
NASDAQ
BTMD
Biote CORPDirector Richard R. Barrera was granted 121,452 stock options in Biote Corp. with an exercise price of $2.20.
NASDAQ
BTMD
Biote CORPBiote Corp. reports that General Counsel Daniel Michael Monico was granted 88,800 employee stock options with an exercise price of $2.19.
NASDAQ
BTMD
Biote CORPBiote Corp. CEO Bret Christensen has acquired stock options, with a portion vesting in April 2027 and the remainder over the following 36 months.
NASDAQ
BTMD
Biote CORPBiote Corp. Chief Financial Officer Robert Peterson has been granted a stock option for 107,169 shares with an exercise price of $1.43, vesting over time starting April 1, 2027.
NASDAQ
BTMD
Biote CORPRichard R. Barrera, a Director and 10% Owner of biote Corp., was granted 150,439 stock options with an exercise price of $3.93, vesting monthly over three years starting July 9, 2025.
NASDAQ
BTMD
Biote CORPDirector Debra L. Morris reports acquisition and disposal of Biote Corp. Class A Common Stock and Restricted Stock Units (RSUs).
NASDAQ
BTMD
Biote CORPDirector Steven J. Heyer acquired stock options for 104,547 shares of Biote Corp. on May 13, 2025.
NASDAQ
BTMD
Biote CORPDirector Dana Lynn Jacoby reports acquisition and disposal of Biote Corp. Class A Common Stock and Deferred Settlement RSUs.
NASDAQ
BTMD
Biote CORPDirector Andrew R. Heyer reports acquisition of stock options and restricted stock units (RSUs) in Biote Corp.
NASDAQ
BTMD
Biote CORPDirector Stephen Mark Cone reports acquisition of stock options and restricted stock units (RSUs) in Biote Corp.
NASDAQ
BTMD
Biote CORPGuines LLC, along with related entities and individuals, increased its holdings in biote Corp. through a series of open market purchases of Class A common stock.
NASDAQ
BTMD
Biote CORPGuines LLC, along with related entities and individuals, reports the acquisition of 1,933 shares of biote Corp. Class A common stock at a weighted average price of $3.296 per share.
NASDAQ
BTMD
Biote CORPGuines LLC, along with related entities and individuals, reported the acquisition of additional shares of biote Corp. (BTMD) common stock at an average price of $3.2703 per share.
NASDAQ
BTMD
Biote CORPGuines LLC, along with related entities and individuals, reported purchasing additional shares of biote Corp. (BTMD) common stock in open market transactions.
NASDAQ
BTMD
Biote CORPGuines LLC, along with related entities and individuals, has increased its holdings in biote Corp. (BTMD) through a series of open market purchases of Class A common stock.
NASDAQ
BTMD
Biote CORPGuines LLC, along with related entities and individuals, has increased its holdings in biote Corp. through a series of open market purchases of Class A common stock.
NASDAQ
BTMD
Biote CORPGuines LLC, along with related entities and individuals, has increased its holdings in biote Corp. through a series of stock purchases in March 2025.
NASDAQ
BTMD
Biote CORPGuines LLC, along with related entities and individuals, reports the acquisition of 106,000 shares of biote Corp. at $3.32 per share, increasing their total holdings to 4,033,547 shares.
NASDAQ
BTMD
Biote CORPExecutive Chairman of Biote Corp., Marc D. Beer, was granted stock options for 495,600 shares of Class A Common Stock on April 1, 2025, according to a Form 4 filing.
NASDAQ
BTMD
Biote CORPRobert Charles Peterson, CFO of Biote Corp., received stock options for 350,000 shares of Class A Common Stock on April 1, 2025.
NASDAQ
BTMD
Biote CORPMary Elizabeth Conlon, General Counsel of Biote Corp., reports acquisition of stock options.
NASDAQ
BTMD
Biote CORPAndrew R. Heyer, a director of Biote Corp., has increased his beneficial ownership through recent purchases of Class A Common Stock.